Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Aditya Sarawgi

Are Wall Street Analysts Predicting Bio-Techne Stock Will Climb or Sink?

Minneapolis, Minnesota-based Bio-Techne Corporation (TECH) develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets. With a market cap of $10.9 billion, Bio-Techne operates through Protein Sciences, and Diagnostics & Spatial Biology segments.

The biotech major has underperformed the broader market over the past year. Bio-Techne stock prices declined 10.9% in 2024 and gained 8.1% over the past year, lagging behind the S&P 500 Index’s ($SPX) surge of 24.1% on a YTD basis and 30.1% over the past 52 weeks.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.